Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Nneka Ufere

Liver Transplant · MGH

View

Dr. Vinay Jahagirdar

Liver Transplant · Medical College of Virginia

View

Dr. Lauren Feld

Liver Transplant · UMass Memorial

View

Dr. Sonali Paul

Liver Transplant · UCMC

View

Dr. Pierre Gholam

Liver Transplant · CWRU

View

Dr. Elliot Tapper

Liver Transplant · UM

View

Dr. Saurabh Sethi

General GI · Oja Health

View

Dr. Sara Horst

IBD · Vanderbilt

View

Dr. Wendi LeBrett

General GI · ModernGut

View

Dr. Treta Purohit

General GI · Oshi Health

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    RGDr. Russell Goodman

    Dr. Russell Goodman

    Gastroenterology · Hepatology & Liver Transplantation
    Massachusetts General Hospital
    russellg

    Research

    Defining Risk in Alcohol-Associated Liver Disease Using the Model for End-Stage Liver Disease

    2025

    Via The American Journal of Gastroenterology

    Jul 29, 2025Journal Article

    Integrating hepatology with addiction care for inpatients with alcohol use disorder reduces future liver-related events.

    ​

    Written by 1 Roon author & 8 others

    Via Hepatology Communications

    Research

    Glycerol-3-phosphate activates ChREBP, FGF21 transcription and lipogenesis in citrin deficiency

    2025

    Via Nature Metabolism

    Research

    Proteomics identifies complement protein signatures in patients with alcohol-associated hepatitis

    2024

    Via JCI Insight

    Research

    No single perfect mouse model of MASH

    2024

    Via Nature Metabolism

    Research

    Cytosolic calcium regulates hepatic mitochondrial oxidation, intrahepatic lipolysis, and gluconeogenesis via CAMKII activation

    2024

    Via Cell Metabolism

    Research

    Prevalence and Clinical Correlation of Cardiometabolic Risk Factors in Alcohol-Related Liver Disease and Metabolic Dysfunction and Alcohol Associated Liver Disease (MetALD)

    2024

    Via Journal of Clinical and Experimental Hepatology

    Research

    Serum Fibroblast Growth Factor-21 Discriminates Between Decompensated Alcohol-Associated Cirrhosis and Severe Alcohol-Associated Hepatitis

    2023

    Via Clinical and Translational Gastroenterology

    Research

    Integrated hepatology and addiction care for inpatients with alcohol use disorder improves outcomes: a prospective study

    2023

    Via Hepatology Communications

    Research

    Salvage of ribose from uridine or RNA supports glycolysis in nutrient-limited conditions

    2023

    Via Nature Metabolism

    Research

    Moderate-high intensity exercise associates with reduced incident alcohol-associated liver disease in high-risk patients

    2023

    Via Alcohol and Alcoholism

    Research

    A genetically encoded tool to increase cellular NADH/NAD ratio in living cells

    2023

    Via Nature Chemical Biology

    Research

    ChREBP is activated by reductive stress and mediates GCKR-associated metabolic traits

    2023

    Via Cell Metabolism

    Research

    Creation of an Inpatient Alcohol Liver Service Improves Early Liver Disease Detection in Patients With Alcohol Use Disorder

    2022

    Via Clinical Gastroenterology and Hepatology

    Research

    Substance use disorder is associated with alcohol-associated liver disease in patients with alcohol use disorder

    2022

    Via Gastro Hep Advances